To determine if IV glutathione is a truly efficacious symptomatic therapy for Parkinsons, larger, randomized, placebo-controlled trials need to be done
Email Update: Non-Traditional Immunizers for COVID-19 and Influenza Immunization Programs, COVID and Influenza Prescribing from Saskatchewan College of Pharmacy Professionals ([email protected]) Hammond J, Fountaine RJ, Yunis C, Fleishaker D, Almas M, Bao W, Wisemandle W, Baniecki ML, Hendrick VM, Kalfov V, Simn-Campos JA
On the heels of Regenerons combinations, Scholar Rocks released results from EMBRAZE, a 24-week Phase 2 study of tirzepatide with or without their anti-(latent) myostatin antibody, apetigromab
Laboratory research record on GLP-1S [PMID: 42313535] PubMed laboratory record discussing GLP-1S in a research context